TNSN01065A1 - Inhibiteur de nhe-1, et composition le contenant - Google Patents
Inhibiteur de nhe-1, et composition le contenantInfo
- Publication number
- TNSN01065A1 TNSN01065A1 TNTNSN01065A TNSN01065A TNSN01065A1 TN SN01065 A1 TNSN01065 A1 TN SN01065A1 TN TNSN01065 A TNTNSN01065 A TN TNSN01065A TN SN01065 A TNSN01065 A TN SN01065A TN SN01065 A1 TNSN01065 A1 TN SN01065A1
- Authority
- TN
- Tunisia
- Prior art keywords
- composition containing
- nhe
- inhibitor
- same
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20043200P | 2000-04-28 | 2000-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN01065A1 true TNSN01065A1 (fr) | 2005-11-10 |
Family
ID=22741697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN01065A TNSN01065A1 (fr) | 2000-04-28 | 2001-04-27 | Inhibiteur de nhe-1, et composition le contenant |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP1276737A1 (es) |
| JP (1) | JP2003531900A (es) |
| KR (1) | KR20020093079A (es) |
| CN (1) | CN1225466C (es) |
| AP (1) | AP2002002651A0 (es) |
| AR (1) | AR028375A1 (es) |
| AU (1) | AU2001235896A1 (es) |
| BG (1) | BG107139A (es) |
| BR (1) | BR0110268A (es) |
| CA (1) | CA2407535A1 (es) |
| CO (1) | CO5221125A1 (es) |
| CR (1) | CR6797A (es) |
| CZ (1) | CZ20023408A3 (es) |
| DZ (1) | DZ3310A1 (es) |
| EA (1) | EA004882B1 (es) |
| EE (1) | EE200200615A (es) |
| GT (1) | GT200100064A (es) |
| HN (1) | HN2001000042A (es) |
| HR (1) | HRP20020851A2 (es) |
| HU (1) | HUP0300651A2 (es) |
| IL (1) | IL152075A0 (es) |
| IS (2) | IS6567A (es) |
| MA (1) | MA26897A1 (es) |
| MX (1) | MXPA02010600A (es) |
| MY (1) | MY133842A (es) |
| NO (1) | NO20025132L (es) |
| NZ (1) | NZ521348A (es) |
| OA (1) | OA12256A (es) |
| PA (1) | PA8513301A1 (es) |
| PE (1) | PE20011270A1 (es) |
| PL (1) | PL357765A1 (es) |
| SK (1) | SK14872002A3 (es) |
| SV (1) | SV2002000418A (es) |
| TN (1) | TNSN01065A1 (es) |
| TR (1) | TR200202439T2 (es) |
| UA (1) | UA73348C2 (es) |
| UY (1) | UY26680A1 (es) |
| WO (1) | WO2001083470A1 (es) |
| YU (1) | YU79602A (es) |
| ZA (1) | ZA200208605B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU51903A (sh) * | 2001-01-31 | 2006-05-25 | Pfizer Products Inc. | Enolati inhibitora izmene natrijum-vodonik tipa-1 |
| CA2469305A1 (en) * | 2001-12-19 | 2003-06-26 | Frank Robert Busch | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| MXPA04008646A (es) * | 2002-05-02 | 2004-12-06 | Pfizer Prod Inc | Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1. |
| FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| ES2220185B1 (es) * | 2002-07-16 | 2006-04-01 | Consejo Sup. De Investig. Cientificas | Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones. |
| PL378111A1 (pl) * | 2003-02-14 | 2006-03-06 | Smithkline Beecham Corporation | Nowe związki |
| RU2518741C1 (ru) * | 2013-03-22 | 2014-06-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030083004A (ko) * | 1998-02-27 | 2003-10-23 | 화이자 프로덕츠 인크. | 허혈 치료용 ｎ-[(치환된 5원 디아자 이불포화고리)카르보닐] 구아니딘 유도체 |
-
2001
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Application Discontinuation
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko active IP Right Grant
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-02-28 EE EEP200200615A patent/EE200200615A/xx unknown
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
-
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN02037A1 (fr) | Sulfonylpyridazinones nouvelles inhibitrices d'aldose reductase et compositions les contenant | |
| TNSN00191A1 (fr) | Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie | |
| TNSN01145A1 (fr) | Derives d'imidazole a noyau aryle ou heteroaryle condense, et compositions les contenant. | |
| BR0313420A (pt) | Quinolonas microbicidas, suas composições e usos | |
| TNSN02009A1 (fr) | Pyrimidinones bicycliques condensees nouvelles, inhibitrices de mmp, et compositions les contenant. | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| TNSN01150A1 (fr) | Pyrimidine-2,4,6- triones inhibitrices de metalloproteinases, et compositions les contenant. | |
| EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| TNSN02011A1 (fr) | Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant | |
| BR0110101A (pt) | N-acil-sulfonamidas promotoras de apoptose | |
| MXPA03006438A (es) | Uso novedoso de una clase peptidica de compuesto para tratar la alodinia u otros tipos diferentes de dolor cronico o fantasmal. | |
| DE60012188D1 (de) | Fungizide | |
| BG106585A (en) | Kinase inhibitors as therapeutic agents | |
| NO20041493L (no) | Kjemiske forbindelser. | |
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| AP2001002205A0 (en) | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase. | |
| BR9806752A (pt) | Ftalazinonas. | |
| ATE355284T1 (de) | Inhibitoren von serinproteasen | |
| PT1448853E (pt) | Melhoramentos relacionados com branqueadores ópticos | |
| BR0209149A (pt) | Ftalazinonas | |
| TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
| MA27549A1 (fr) | N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones | |
| ATE355101T1 (de) | Inhibitoren von serin proteasen | |
| SE9901077D0 (sv) | Novel use | |
| TNSN01065A1 (fr) | Inhibiteur de nhe-1, et composition le contenant |